The FDA has granted Breakthrough Therapy designation for litifilimab for the treatment of cutaneous lupus erythematosus, a chronic autoimmune skin disease.
The Manila Times on MSN
Senate approves proposed lupus prevention law
SEN. Bong Go has hailed the approval on third and final reading of Senate Bill (SB) 1513, or the proposed Comprehensive Lupus ...
Designation is based on the breadth of available litifilimab data, including the Phase 2 LILAC study result that showed ...
Our most recent episode of The Expert Series podcast explores the newly released SLE treatment guidelines and how they might affect patient care.
The FDA has granted breakthrough therapy designation for litifilimab in patients with cutaneous lupus erythematosus, ...
Biogen BIIB announced that the FDA has granted the Breakthrough Therapy designation to its investigational, first-in-class, ...
CONGRESSWOMAN Girlie Veloso of Malasakit@Bayanihan Party-list filed House Bill (HB) 7302 in the House of Representatives on ...
Everyday Health on MSN
How to identify lupus rash and other skin symptoms of the condition
This autoimmune disease may impact your skin as well as your nails and hair. Learn what to look for to treat lupus more effectively.
New findings from a Phase II study indicate that antenatal treatment with the FcRn blocker nipocalimab resulted in low fetal drug exposure and transient reductions in infant IgG levels at birth, ...
The striking benefits achieved with emerging treatment options for recalcitrant connective tissue diseases offer the ...
Under legislation that has cleared a House subcommittee, Iowans would be allowed to buy the medications ivermectin and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results